Crisafulli Ernesto, Micheletto Claudio, Campisi Alessio, Vocale Emanuele, Schiena Chiara, Sartori Giulia, Gaburro Gianluca, Felici Elide, Infante Maurizio
Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
Pulmonology Unit, Verona Integrated University Hospital, Verona, Italy.
Thorac Cancer. 2025 Jan;16(2):e15515. doi: 10.1111/1759-7714.15515.
In early-stage lung cancer, lung function appears to be less compromised after segmentectomy than lobectomy, though the advantage seems modest. We aimed to re-assess postoperative lung function in surgical patients, with a particular focus on the diffusion capacity for carbon monoxide (DL). We evaluated all patients who underwent either lobectomy or segmentectomy for T1a-c lung cancer at our center between March 2016 and March 2023. From January to June 2024, patients who had undergone segmentectomy, along with a matched cohort of patients who had undergone lobectomy, were invited for a repeat lung function evaluation. Patients were matched 1:1 based on age, sex, surgical approach, year in which the procedure was performed, and tumor location. Lung function testing data including DL were then compared to preoperative measures. During the study period, 480 patients received a lobectomy, and 97 received a segmentectomy. Complete lung function evaluation for the study was available for 52 patients (26 matched pairs). The median time from lung resection to repeat spirometry was 35 months. A modest reduction of lung function measures was observed in the segmentectomy group. Conversely, all lung function measures, including DL, were significantly impaired in the lobectomy group. In early-stage lung cancer, patients who perform segmentectomy demonstrated better long-term lung function preservation compared to those who underwent lobectomy. Whenever feasible, segmentectomy should be considered the procedure of choice for early-stage lung cancer patients.
在早期肺癌中,肺段切除术相比肺叶切除术对肺功能的损害似乎更小,尽管这种优势似乎并不显著。我们旨在重新评估手术患者术后的肺功能,特别关注一氧化碳弥散量(DL)。我们评估了2016年3月至2023年3月期间在我们中心接受T1a-c期肺癌肺叶切除术或肺段切除术的所有患者。在2024年1月至6月期间,邀请接受肺段切除术的患者以及一组匹配的接受肺叶切除术的患者进行重复肺功能评估。根据年龄、性别、手术方式、手术年份和肿瘤位置,患者按1:1进行匹配。然后将包括DL在内的肺功能测试数据与术前测量值进行比较。在研究期间,480例患者接受了肺叶切除术,97例接受了肺段切除术。共有52例患者(26对匹配患者)完成了本研究的肺功能评估。从肺切除到重复肺量计检查的中位时间为35个月。肺段切除术组的肺功能指标有适度下降。相反,肺叶切除术组的所有肺功能指标,包括DL,均有显著受损。在早期肺癌中患者,与接受肺叶切除术的患者相比,接受肺段切除术的患者表现出更好的长期肺功能保留。只要可行,肺段切除术应被视为早期肺癌患者的首选手术方式。